开拓药业启动化妆品原料KT-939全球销售

财中社2025-05-08

5月8日，开拓药业（09939）发布公告，正式启动美白祛斑功效性化妆品原料KT-939的全球销售业务。经过两年的研发和商业化准备，KT-939已成功完成首份原料销售，标志着公司正式进入功效性化妆品原料市场。　　该业务将与外用创新药物研发和B2C功效性化妆品产品业务共同构成公司的“三驾马车”商业模式，为公司的可持续盈利增长和长期稳定发展奠定基础。　　KT-939是一种高效的酪氨酸酶抑制剂，能够显著...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2533180906?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-08 20:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2533180906","market":"hk","top_or_hot":-1,"title":"开拓药业启动化妆品原料KT-939全球销售","media":"财中社","content":"<div>\n<p>5月8日，开拓药业（09939）发布公告，正式启动美白祛斑功效性化妆品原料KT-939的全球销售业务。经过两年的研发和商业化准备，KT-939已成功完成首份原料销售，标志着公司正式进入功效性化妆品原料市场。　　该业务将与外用创新药物研发和B2C功效性化妆品产品业务共同构成公司的“三驾马车”商业模式，为公司的可持续盈利增长和长期稳定发展奠定基础。　　KT-939是一种高效的酪氨酸酶抑制剂，能够显著...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202505083399709697.html\">网页链接</a>\n\n</div>\n","source":"stock_eastmoney","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>开拓药业启动化妆品原料KT-939全球销售</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n开拓药业启动化妆品原料KT-939全球销售\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-08 20:43 北京时间&nbsp;&nbsp;&nbsp;<a href=http://finance.eastmoney.com/a/202505083399709697.html><strong>财中社</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>5月8日，开拓药业（09939）发布公告，正式启动美白祛斑功效性化妆品原料KT-939的全球销售业务。经过两年的研发和商业化准备，KT-939已成功完成首份原料销售，标志着公司正式进入功效性化妆品原料市场。　　该业务将与外用创新药物研发和B2C功效性化妆品产品业务共同构成公司的“三驾马车”商业模式，为公司的可持续盈利增长和长期稳定发展奠定基础。　　KT-939是一种高效的酪氨酸酶抑制剂，能够显著...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202505083399709697.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0541501648.USD","symbol_name":"ALLSPRING  EMERGING MARKETS EQUITY \"A\" (USD) ACC","start_time":0,"source_url":"http://finance.eastmoney.com/a/202505083399709697.html","article_id":"2533180906","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2533180906","pubTimestamp":1746708191,"columns":[],"sourceInfo":{"source_id":"stock_eastmoney","name":"东方财富"},"weMediaInfo":null,"summary":"5月8日，开拓药业（09939）发布公告，正式启动美白祛斑功效性化妆品原料KT-939的全球销售业务。经过两年的研发和商业化准备，KT-939已成功完成首份原料销售，标志着公司正式进入功效性化妆品原料市场。该业务将与外用创新药物研发和B2C功效性化妆品产品业务共同构成公司的“三驾马车”商业模式，为公司的可持续盈利增长和长期稳定发展奠定基础。","collect":0,"end_time":0,"defaultTopTitle":"eastmoney.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0541501648.USD":"ALLSPRING  EMERGING MARKETS EQUITY \"A\" (USD) ACC","BK4115":"综合电信业务","LU0541502299.USD":"ALLSPRING  EMERGING MARKETS EQUITY \"I\" (USD) ACC","KT":"韩国电信"},"translate_title":"Kintor Pharmaceutical launches global sales of cosmetic raw material KT-939","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KT":1},"content_text":"5月8日，开拓药业（09939）发布公告，正式启动美白祛斑功效性化妆品原料KT-939的全球销售业务。经过两年的研发和商业化准备，KT-939已成功完成首份原料销售，标志着公司正式进入功效性化妆品原料市场。　　该业务将与外用创新药物研发和B2C功效性化妆品产品业务共同构成公司的“三驾马车”商业模式，为公司的可持续盈利增长和长期稳定发展奠定基础。　　KT-939是一种高效的酪氨酸酶抑制剂，能够显著抑制黑色素生成，并具有抗氧化和抗炎作用。公司前期研究显示，KT-939在抑制酪氨酸酶活性方面的效果优于目前已应用于化妆品领域的同类化合物。此外，KT-939已通过多项安全性检测，并获得国际化妆品成分命名委员会和日本化妆品工业会的审查批准，正在积极推进其他国家的准入申请。公司还计划通过参与国际展会，寻求合作机会，进一步拓展化妆品原料业务市场。（文章来源：财中社）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2533180906","isCrawlerRequest":true}